Following the introduction of life-saving glucocorticoid replacement 60 years ago, congenital
adrenal hyperplasia (CAH) has evolved from being perceived as a paediatric disorder to …

Congenital adrenal hyperplasia (CAH) is a term that encompasses a wide range of
conditions that affect the adrenals. Diagnosis and treatment before birth are important as …

Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder caused by a
defect in enzymes necessary for adrenal steroidogenesis. Deficient cortisol synthesis leads …

The most frequent form of congenital adrenal hyperplasia (CAH) is steroid 21-hydroxylase
deficiency, accounting for more than 90% of cases. Affected patients cannot synthesize …

Patients with rare and complex diseases such as congenital adrenal hyperplasia (CAH)
often receive fragmented and inadequate care unless efforts are coordinated among …

Objective: We developed clinical practice guidelines for congenital adrenal hyperplasia
(CAH). Participants: The Task Force included a chair, selected by The Endocrine Society …

Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder of adrenal steroid
biosynthesis affecting 1/10,000 to 1/15,000 live births. The most common form is 21 …

CONONGENITAL ADRENAL hyperplasia (CAH) is an inborn error of metabolism that can
produce life-threatening disease in the first one to three weeks of life, unless properly …

Context: No consensus exists for management of adults with congenital adrenal hyperplasia
(CAH) due to a paucity of data from cohorts of meaningful size. Objective: Our objective was …